Company / Total Assets
Caribou Biosciences, Inc. Total Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$175.4M
FY2025
5-year range
$175.4M / $442.4M
FY2021-FY2025
Trend
-44.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $432M to $175M over the past 2 years.
Based on SEC 10-K filings.
$175M in FY2025 with a 3-year CAGR of -22.3%.
Declined from $432M to $175M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -22.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -22.3%, indicating a declining trend.
- In FY2025, total assets decreased 44.0% year-over-year.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $175.4M | -44.0% |
| FY2024 | $313.3M | -27.5% |
| FY2023 | $432.2M | +15.6% |
| FY2022 | $373.8M | -15.5% |
| FY2021 | $442.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026